1. Home
  2. Labeler Index
  3. Macleods Pharmaceuticals Limited
  4. 33342-146
  5. NDC Package Code: 33342-146-12 Ziprasidone Hydrochloride

NDC Package 33342-146-12 Ziprasidone Hydrochloride

Capsule Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
33342-146-12
Package Description:
10 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK
Product Code:
33342-146
Proprietary Name:
Ziprasidone Hydrochloride
Non-Proprietary Name:
Ziprasidone Hydrochloride
Substance Name:
Ziprasidone Hydrochloride
Usage Information:
Ziprasidone hydrochloride capsules are indicated for the treatment of schizophrenia. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone’s greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [see Warnings and Precautions (5.2)]. Prolongation of the QTc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. In many cases this would lead to the conclusion that other drugs should be tried first. Whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see Warnings and Precautions (5.2)]
11-Digit NDC Billing Format:
33342014612
NDC to RxNorm Crosswalk:
  • RxCUI: 313776 - ziprasidone HCl 40 MG Oral Capsule
  • RxCUI: 313776 - ziprasidone 40 MG Oral Capsule
  • RxCUI: 313776 - ziprasidone (as ziprasidone hydrochloride monohydrate) 40 MG Oral Capsule
  • RxCUI: 313777 - ziprasidone HCl 60 MG Oral Capsule
  • RxCUI: 313777 - ziprasidone 60 MG Oral Capsule
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Macleods Pharmaceuticals Limited
    Dosage Form:
    Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ZIPRASIDONE HYDROCHLORIDE 60 mg/1
    • Pharmacologic Class(es):
  • Atypical Antipsychotic - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA204375
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    02-18-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    33342-146-0960 CAPSULE in 1 BOTTLE
    33342-146-51300 CAPSULE in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 33342-146-12?

    The NDC Packaged Code 33342-146-12 is assigned to a package of 10 blister pack in 1 carton / 10 capsule in 1 blister pack of Ziprasidone Hydrochloride, a human prescription drug labeled by Macleods Pharmaceuticals Limited. The product's dosage form is capsule and is administered via oral form.

    Is NDC 33342-146 included in the NDC Directory?

    Yes, Ziprasidone Hydrochloride with product code 33342-146 is active and included in the NDC Directory. The product was first marketed by Macleods Pharmaceuticals Limited on February 18, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 33342-146-12?

    The 11-digit format is 33342014612. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-233342-146-125-4-233342-0146-12